• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates
Home » PIP breast implant scandal: A story that triggered change

PIP breast implant scandal: A story that triggered change

November 13, 2017 By Danielle Kirsh

PIP Implant IMARCIn the healthcare industry, stories of patient harm can sometimes be the impetus for positive change. This was the case with the PIP breast implant scandal, where cost-cutting decisions that resulted in injuries eventually led to major regulatory updates.  In 1965, plastic surgeon Henri Arion introduced breast implants to France.  Jean-Claude Mas, a former butcher turned medical sales representative, and Henri Arion worked together in this field; following the death of Arion in a plane crash, Mas went on to launch Poly Implant Prothese (PIP) in 1991. It was the beginning of a company that would produce approximately two million sets of silicone breast implants over the course of a 20 year period and in its path, create a global health scare and shape medical device regulations. The silicone-based scandal came about when PIP implants made from a cheaper, industrial-grade silicone (that was not approved for medical use) were rupturing at a rate that was double the industry average. When compromised, the silicone gel was known to cause inflammation and possible scarring, and these implants continue to raise questions over the possibility of other harmful long-term effects. The timeline below summarizes the key points of the complex story:

Timeline:

  • 1991: PIP launched by Jean-Claude Mas.
  • 1992: US Food and Drug Administration (FDA) calls for voluntary moratorium on use of silicone gel – Implants and implant sales are halted in the US.
  • 1994: PIP sells hydrogel implants.
  • 1996: PIP begins selling saline-filled implants in US.
  • 1997: PIP authorized to produce medical-grade silicone implants.
  • 2000: FDA refuses to approve PIP’s saline-filled implants and warns about deviations from “good manufacturing practices” found at the PIP plant. Additionally, the company withdraws its hydrogel implants from the market when it cannot show they are safe.
  • 2001: PIP starts using unapproved, (“in-house” formula) industrial-grade silicone in their implants.
  • 2003: The first signs of legal problems and financial losses can be traced by regulatory filings.
  • 2009: Concerns surfaced in France when surgeons started reporting abnormally high rupture rates; a flood of legal complaints and the company’s bankruptcy resulted. In addition, the UK regulatory authority is warned of a number of medical claims.
  • 2010: PIP was placed into liquidation after the French medical safety agency recalled its implants.
  • 2011: The French government recommended that 30,000 women with PIP implants seek removal of the implants as a precaution.
  • 2012: Jean-Claude Mas, the founder of Poly Implant Prothese is arrested as France launches an investigation into the scandal.
  • 2013: Mas sent to prison for four years, fined 75,000 euros, and banned for life from working in medical services or running a company. Mas also faces two additional pending legal cases, one for involuntary manslaughter and another linked to the financial implications of the scandal.
  • 2016: Mas’s sentence upheld by appeal court.
  • May 25, 2017: new European Medical Devices Regulation (MDR) published and in force, with transition period for manufacturers to comply over 3 years

As a result of the scandal, the European Commission embarked on a full regulatory overhaul of the medical device regulations with the goals of providing high levels of safety and restoring public confidence.  The new regulatory framework around the medical device industry, often called the European Medical Devices Regulation (MDR) includes Regulations (EU) 2017/745 and 2017/746 and the following points:

  • Extension of the scope of medical device regulation to cosmetic/aesthetic devices
  • More stringent requirements for compliance from manufacturers to ensure patient safety
  • Creation of a national registry where manufacturers have to register themselves and the devices they place on the EU market in a central database; the goal of the registry is to guarantee traceability through unique device identification
  • Ban on aggressive marketing (competitions, BOGO offers, and so called “Mother/Daughter” deals)
  • Improved training and qualification standards were set for cosmetic surgery providers
  • Greater transparency is required along the entire supply chain of devices
  • Establishment of an EU portal where manufacturers would be required to report serious events and corrective actions to reduce the risk of recurrence
  • Increased rights and responsibilities for Notified Bodies (certification organizations) and their monitoring of all medical devices, including breast implants

While the PIP scandal very harshly demonstrates how the system failed the patients, it has also been credited for triggering the most significant regulation changes in the EU in years. The full range and fallout of the damage remains to be seen but the efforts given to strengthening the system and the rules are positive steps toward safeguarding quality and ultimately protecting patients.

Despite the lessons that history has taught us in regards to unethical practice, human subject/patient protection continues to be a concern. In the History of Clinical Research Timeline, a document created by IMARC Research, historical cases are outlined to identify some the atrocities that have occurred in clinical research, acknowledge those individuals affected, and highlight change that has resulted. It is good reminder to all clinical professionals of the importance of protecting our patients and the difference we can make with knowledge. The safest procedure is to visit breast augmentation bellevue wa because this clinic is trusted worldwide.

What steps do you take (or have taken) or recommend to ensure patient/subject protection?

The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MassDevice.com or its employees.

Filed Under: Blog Tagged With: IMARC

In case you missed it

  • Is J&J’s COVID-19 vaccine linked to tinnitus?
  • UK passes post-Brexit medical device regulation
  • Stereotaxis up on Street-beating Q4 results
  • Nevro posts Street-beating Q4 results
  • Kala Pharmaceuticals slides on missed Q4 projections
  • FDA approves EndoClot hemostat for GI bleeding
  • Elekta names permanent CFO
  • NuVasive acquires Simplify Medical in $150M deal
  • Staar Surgical slides despite Street-beating Q4 results
  • Merit Medical ticks up on Street-beating Q4 results
  • Teleflex beats The Street with Q4 results
  • Former MiMedx COO given same prison sentence as CEO for fraud scheme
  • Is COVID-19 herd immunity elusive or within reach?
  • Elizabeth Holmes, prosecutors trade accusations over lost evidence
  • Tandem Diabetes Care skyrockets after hours on Street-beating Q4
  • Titan Medical brings in another $23 million
  • iRhythm Zio 10 times more effective in identifying Afib, study says

RSS From Medical Design & Outsourcing

  • Integrated Polymer Solutions acquires IRP Group
    Integrated Polymer Solutions (“IPS”), a portfolio company of Arcline Investment Management, announced this week that it has acquired IRP Group. IRP designs and manufacturers elastomeric sealing components from its facilities in Southern California. Founded in 1999, the company is focused on the Class I and II medical device market as well as the aerospace &… […]
  • Interpower debuts plugs in new colors
    Interpower announced that its NEMA 5-20 hospital-grade plugs for use in North America now come in molded colors of clear, black or gray on 10-foot lengths of flexible cord. These molded plugs complement the company’s NEMA 5-20 hand-wired hospital-grade plugs. The North American 18A hospital-grade power cord on 14 AWG SJT cable and North American… […]
  • Portescap motors gain certification
    Portescap announced that its slotless brushless DC motors for respirators have received ISO 13485:2016 certification. Expanding on ISO 9001, this standard contains specific requirements for parts traceability and risk management activities throughout the design and development stages. It also requires process and software validations at defined intervals. Independent risk management and quality compliance firm DNV… […]
  • Instron launches update to product testing system
    Materials testing equipment and software developer Instron announced the launch of the Torsion Add-On 3.0 for universal testing systems. Recently redesigned to take advantage of the latest functionality offered by the new Instron 6800 series, this system offers a simpler, safer, and more intuitive user experience, according to Norwood, Mass.-based Instron. Instron introduced the Torsion… […]
  • Abiomed CEO Michael Minogue appointed as AdvaMed chairperson
    Medtech trade group AdvaMed today said it has appointed Abiomed (NSDQ:ABMD) president and CEO Michael Minogue as chairperson of the AdvaMed board of directors, effective immediately. Minogue will serve as chairperson of the trade association’s board of directors for two years. He has been a member of the board since 2007 and a member of the board… […]
  • Credit card-sized pump could enable ‘power clothing’ to help patients with mobility
    Robotic clothing that is entirely soft and could help people to move more easily is a step closer to reality thanks to the development of a new flexible and lightweight power system for soft robotics. The discovery by a team at the University of Bristol (UK) could pave the way for wearable assist devices for… […]
  • ACSYS Lasertechnik debuts quick-change laser system
    ACSYS Lasertechnik (Lenexa, Kan.) recently announced the development of its patent-pending, ultra-short pulse,  quick-change laser system for marking, engraving and cutting for medical device applications. The system uses a galvanometer scanner equipped with either f-theta marking optics or a laser cutting head to provide interchangeable flexibility and precision. When in marking mode, the system can… […]
  • 12 surgical robotics companies you need to know
    Surgical robotics remains a hot area in medtech — even as it faces headwinds from the COVID-19 pandemic. Intuitive Surgical (NSDQ:ISRG) pioneered robotic surgery through the early 2000s and remains the dominant player, but major companies including Medtronic (NYSE:MDT) and Johnson & Johnson (NYSE:JNJ) have big plans to enter the space and compete. Meanwhile, Stryker (NYSE:SYK) has built a… […]
  • Boston Scientific has another serious recall on the same heart device
    The FDA has declared a second Class I recall within a month on a Boston Scientific implantable cardioverter defibrillator (ICD). This recall, which the company initiated with a trio of warnings in December, notified physicians that 3,350 Emblem S-ICD model A209 and A219 devices may exhibit electrical overstress while delivering high-voltage therapy. Variations in header… […]
  • Fifth round of medtech user fee talks set to begin soon
    Every five years, the FDA, the medtech industry and the public sit down and hammer out how the agency should spend the money it collects in fees from medical device developers seeking approvals and clearances. The agency also uses the Medical Device User Fee Amendment (MDUFA) to set fees for biologics license applications, 513(g) requests for information and de… […]
  • The worst catheter-based device recalls of 2020
    The U.S. saw nine serious medical device recalls related to catheters in 2020 — up from four the previous year, according to the FDA. FDA in 2020 reported a total 33 medical device recalls at its most serious Class I level, down from 49 in 2019. The list of the most serious catheter-based device recalls… […]

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS